Design to come?

WP_Post Object
(
    [ID] => 1054
    [post_author] => 3
    [post_date] => 2021-11-30 11:49:47
    [post_date_gmt] => 2021-11-30 16:49:47
    [post_content] => 
    [post_title] => Intensity Therapeutics Announces New Clinical Data Presentation for its Lead Asset, INT230-6, in Breast Cancer, at the 2021 San Antonio Breast Cancer Symposium® in December
    [post_excerpt] => 
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => intensity-therapeutics-announces-new-clinical-data-presentation-for-its-lead-asset-int230-6-in-breast-cancer-at-the-2021-san-antonio-breast-cancer-symposium-in-december
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2021-11-30 11:49:47
    [post_modified_gmt] => 2021-11-30 16:49:47
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://vcapital.com/?post_type=news&p=1054
    [menu_order] => 0
    [post_type] => news
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
)